Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 45,902	$ 7,778
Other Assets
Total Current Assets	45,902	7,778
Convertible Note Receivable
Accrued interest receivable
Patents
Total assets	45,902	7,778
Current Liabilities
Accounts payable	800,558	797,908
Accrued expenses	1,794,534	1,660,933
Due to related party
Loan payable related party	27,000
Notes payable exceeding statute of limitations	773,279	773,279
Total Current Liabilities	3,395,371	3,232,120
Total Liabilities	3,395,371	3,232,120
Common stock (Par value $0.001 authorized 250,000,000 shares, issued and outstanding 57,112,506 at June 30, 2023 and December 31, 2022	57,113	57,113
Additional paid in capital	42,335,725	42,335,725
Common stock-warrants	1,206,913	1,206,913
Accumulated deficit	(46,949,220)	(46,824,093)
Total stockholders’ deficit	(3,349,469)	(3,224,342)
Total Liabilities and stockholders' deficit	$ 45,902	$ 7,778